Stay updated on Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision history now includes v3.5.0 and removes v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T18:04:52.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The revision history now shows Revision: v3.4.3 as the latest version and removes Revision: v3.4.2 from the history.
    Difference
    0.1%
    Check dated 2026-03-11T15:21:26.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    Added a new revision label (v3.4.2) to the record history. Removed a government funding notice and the earlier revision (v3.4.1).
    Difference
    0.6%
    Check dated 2026-02-11T01:54:12.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and operating status was added, and the page now shows Revision: v3.4.1; the previous Revision: v3.4.0 was removed.
    Difference
    0.6%
    Check dated 2026-02-03T23:01:35.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Adds a 'Show glossary' option and updates color-coded change highlights, with the revision label changed from v3.3.4 to v3.4.0.
    Difference
    0.7%
    Check dated 2026-01-27T20:36:21.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    On 2025-12-18, the record shows updates posting Results, Adverse Events, and Study Status (Version 29, Revision: v3.3.3). The 2024-11-25 entry reflects deletion of 'Results Submitted' (Revision: v3.3.2) and removal of the HHS Vulnerability Disclosure.
    Difference
    0.6%
    Check dated 2025-12-22T22:20:03.000Z thumbnail image

Stay in the know with updates to Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page.